4//SEC Filing
Giladi Moshe 4
Accession 0001562180-24-001984
CIK 0001645113other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:33 PM ET
Size
12.4 KB
Accession
0001562180-24-001984
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Giladi Moshe
Chief Science Officer
Transactions
- Award
Ordinary Shares
2024-02-27$16.30/sh+51,124$833,321→ 69,771 total - Award
Stock Options (Right to buy)
2024-02-27$16.30/sh+78,174$1,274,236→ 78,174 totalExercise: $16.30From: 2025-02-27Exp: 2034-02-26→ Ordinary Shares (78,174 underlying)
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 78,174 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0002001639
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:33 PM ET
- Size
- 12.4 KB